The widow and son of a Beaumont man are suing the maker of the popular diabetes drug Avandia, claiming it contributed to the man’s death from a heart attack.
This man died the same day a scientific analysis was published in the New England Journal of Medicine about more severe risks involved with taking Avandia, such as heart attacks and even death. He had been taking a form of Avandia called Avandamet mixed with another diabetes drug for around two years.
His widow and son filed the lawsuit against GlaxoSmithKline pharmaceutical company. Their lawyer strongly believed that evidence will show that the company new about some of the risks involved in taking Avandia, but didn’t bother to tell anyone about it and continued to supply consumers. Of course, GlaxoSmithKline firmly disagrees and says that their product is safe and thorough. The analysis in the New England Journal of Medicine concluded that Avandia could raise patients’ risk of heart attack by more than 40 percent. The Food and Drug Administration will now be much more strict by requiring stronger warnings about heart failure on Avandia.
For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.